Exposure of the eyes to near-horizon sunshine may be a trigger for multiple sclerosis

Medical Hypotheses

Volumn 74, Issue 3, 2010, Pages 428-432

  Bains, William ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CAUCASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; GEOGRAPHIC DISTRIBUTION; HUMAN; INFRARED RADIATION; LATITUDE; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; OPTIC NERVE LESION; PATHOGENESIS; SOLAR RADIATION; SUN EXPOSURE; TIME; ULTRAVIOLET RADIATION;

CAUSALITY; COMORBIDITY; ENVIRONMENTAL EXPOSURE; EUROPE; HUMANS; MULTIPLE SCLEROSIS; OPTIC NERVE INJURIES; PROPORTIONAL HAZARDS MODELS; RADIATION INJURIES; RISK ASSESSMENT; RISK FACTORS; SUNLIGHT;

EID: 77649276030     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.09.054     Document Type: Article

References (77)

1. Kurtzke J.F., Heltberg A. Multiple sclerosis in the Faroe Islands: an epitome. J Clin Epidemiol 2001, 54:1-22.
2. Warner H.B., Carp R.I. Multiple sclerosis etiology - an Epstein Barr hypothesis. Med Hyp 1988, 25(2):93-97.
3. Simon J, Neubert WJ. The pathogenesis of multiple sclerosis: reconsideration of the role of viral agents and defence mechanisms. Med Hyp 1996;46, 537-43.
4. Asherio A., Munger K.L., Lennette E.T., Spiegelman D., Hernan M.A., Olek M.J., et al. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. J Am Med Assoc 2001, 286(24):3083-3088.
5. Tucker W.G., Paskauskas R.A. The MSMV hypothesis: measles virus and multiple sclerosis, etiology and treatment. Med Hyp 2008, 71:682-689.
6. Pugliatti M., Harbo H.F., Holmoy T., Kampman M.T., Myhr K.M., Riise T., et al. Environmental risk factors in multiple sclerosis. Acta Neurol Scand 2008, 117(Suppl. 188):34-40.
7. Nanji A.A., Narod S. Multiple sclerosis, latitude and dietary fat: is pork the missing link?. Med Hyp 1986, 20(3):279-282.
8. Malosse D., Perron H., Sasco A., Seigneurin J.M. Correlation between milk and dairy product consumption and multiple sclerosis: a world-wide study. Neuroepidemiology 1992, 11:304-312.
9. Kampman M.T., Wilsgaard T., Mellgren S.I. Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle. J Neurol 2007, 254:471-477.
10. Hutter C. On the causes of multiple sclerosis. Med Hyp 1993, 41(2):93-96.
11. Hutter C.D.D., Laing P. Multiple sclerosis: sunlight, diet, immunology and aetiology. Med Hyp 1996, 46(2):67-74.
12. Dyment D.A., Ebers G.C., Sadovnick A.D. Genetics of multiple sclerosis. Lancet Neurol 2004, 3(2):104-110.
13. Rosen L.N., Livingstone I.R., Rosenthal N.E. Multiple sclerosis and latitude: a new perspective on an old association. Med Hyp 1991, 36:376-378.
14. Kurtzke J.F. Geographic distribution of multiple sclerosis: and update with special reference to Europe and the Mediterranean region. Acta Neurol Scand 1980, 62:65-80.
15. Kurtzke J.F., Gudmundsson K.R., Bergmann S. Multiple sclerosis in Iceland. Neurology 1982, 32:143.
16. Kurtzke J.F. Some epidemiological trends in multiple sclerosis. Trends Neurosci 1983, 6:75-80.
17. Sadovnick A.D., Ebers G.C. Epidemiology of multiple sclerosis: a critical overview. Can J Neurol Sci 1993, 20(1):17-29.
18. Ebers G.C., Sadovnick A.D. The geographic distribution of multiple sclerosis: a review. Neuroepidemiology 1993, 12(1):1-5.
19. Kurtzke J.F. Multiple sclerosis in time and space - geographic clues to cause. J Neurovirol 2000, 6(Suppl. 2):S134-S140.
20. Carlyle I.P. Multiple sclerosis: a geographical hypotheses. Med Hyp 1997, 49:477-486.
21. Armitage E.L., Aldhous M.C., Anderson N., Drummond H.E., Riemersma R.A., Ghosh S., et al. Incidence of juvenile-onset Crohn's disease in Scotland: association with northern latitude and affluence. Gastroenterology 2004, 127:1051-1057.
22. Freedman D.M., Dosemeci M., Alavanja M.C.R. Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates. Occup Environ Med 2000, 57:418-421.
23. van der Mei I.A.F., Ponsonby A.-L., Blizzard L., Dwyer T. Regional variation in multiple sclerosis prevalences in Australia and its association with ambient ultraviolet radiation. Neuroepidemiology 2001, 20:168-174.
24. van der Mei I.A.F., Ponsonby A.-L., Dwyer T., Blizzard I., Simmons R., Taylor B.V., et al. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case control study. Brit Med J 2003, 327:1-6.
25. Ponsonby A.-L., McMichael A.J., van der Mei I.A.F. Ultraviolet radiation and autoimmune disease: insights from epidemiological research. Toxicology 2002, 181:71-78.
26. Goldacre M.J., Seagroatt V., Yeates D., Acheson E.D. Skin cancer in people with multiple sclerosis: a record linkage study. J Epidemiol Commun Health 2004, 59:142-144.
27. Neutel C.I. Multiple sclerosis and the Canadian climate. J Chron Dis 1980, 33:47-56.
28. Gronning M., Mellgren S.I. Multiple sclerosis in the two northernmost counties of Norway. Acta Neurol Scand 1985, 72(3):321-327.
29. Svenson L.W., Warren S., Warren K., Metz L.M., Patten S.B., Schopflocher D.P. Prevalence of multiple sclerosis in First Nations people of Alberta. Can J Neurol Sci 2007, 34:175-180.
30. Miller D.H., Ormerod I.E., McDonald W.I., MacManus D.G., Kendall B.E., Kingsley D.P., et al. The early risk of multiple sclerosis after optic neuritis. J Neurol Neurosurg Psychiat 1988, 51:1569-1571.
31. Soderstrom M., Ya-Ping J., Hillert J., Link H. Prognosis for multiple sclerosis from MRI, CSF and HLA findings. Neurology 1998, 50:708-714.
32. Kheradvar A., Tabassi A.R., Nikbin B., Khosrabi F., Naroueynejad M., Moradi B., et al. Influence of HLA on progression of optic neuritis to multiple sclerosis: results of a four-year follow-up study. Mult Scler 2004, 10(5):526-531.
33. Yannuzzi L.A., Fisher Y.L., Kreuger A., Slaker J. Solar retinopathy: a photobiological and geophysical analysis. Trans Am Opthamol Soc 1987, 85:120-158.
34. Elterman L. UV, visible and IR attenuation to altitudes of 50km, 1968. Air Force environmental paper #285 (AFCRL-68-0153). Bedford, MA, USA: Air Force Cambridge Research Laboratories; 1968.
35. Gueymard C. SMARTS2, a simple model for the atmospheric radiative transfer of sunshine: algorithms and performance assessment. (Working paper FSEC-PF-270-95). Orlando, FL, USA: Florida Solar Energy Center, University of Central Florida; 1995.
36. Debouverie M., Pittion-Vouyovich S., Louis S., Roedered T., Guillemin F. Increasing incidence of multiple sclerosis among women in Lorraine, Eastern France. Mult Scler 2007, 13(8):962-967.
37. Gray O.M., McDonnell G.V., Hawkins S.A. Factors affecting the rising prevalence of multiple sclerosis in the North-East of Ireland. Mult Scler 2008, 14:880-886.
38. Houzen H., Niino M., Hata D., Nakano F., Kikuchi S., Fukazawa T., et al. Increasing prevalence and incidence of multiple sclerosis in Northern Japan. Mult Scler 2008, 14:887-892.
39. Kinnunen E. Multiple sclerosis, in Finland: evidence of increasing frequency and uneven geographic distribution. Neurology 1984, 34:457-461.
40. Ranzato F., Perini P., Tzintzeva E., Tiberio M., Calabrese M., Ermani M., et al. Increasing frequency of multiple sclerosis in Padova, Italy: a 30year epidemiological survey. Mult Scler 2003, 9(4):387-392.
41. Sumelahti ML, Tienari PJ, Wikstrom J, Palo J, Hakama M. Increasing prevalence of multiple sclerosis in Finland. Acta Neurol Scand 2001;103:153-58.
42. Warren S.A., Svenson L.W., Warren K.G. Contribution of incidence to increasing prevalence of MS in Alberta, Canada. Mult Scler 2008, 14:872.
43. Donnan P.T., Parratt J.D.E., Wilson S.V., Forbes R.B., O'Riordan J.I., Swingler R.J. Multiple sclerosis in Tayside, Scotland: detection of clusters using a spacial statistic. Mult Scler 2005, 11(4):403-408.
44. Barlow J.S. The geographic distribution of multiple sclerosis - some contributions from the recent non-English literature. Neurology 1971, 21:353-357.
45. Bhigjee A., Moodley K., Ramkisson K. Multiple sclerosis in KwaZulu, Natal, South Africa: an epidemiological and clinical study. Mult Scler 2007, 13:1095-1099.
46. Celius E.G., Vandik B. Multiple sclerosis in Oslo, Norway: prevalence on 1 January 1995 and incidence over a 25-year period. Eur J Clin Nutr 2001, 8(5):463-469.
47. Cendrowski W.S. Multiple sclerosis in a small urban community in central Poland. J Neurol Sci 1965, 2:82-86.
48. Dahl O.P., Aarseth J.H., Myhr K.M., Nyland H. Multiple sclerosis in Nord-Trondlelag County, Norway: a prevalence and incidence study. Acta Neurol Scand 2004, 109:378-384.
49. Dean G. Annual incidence, prevalence and mortality of multiple sclerosis in white South-african-born and in white immigrants to South Africa. Brit Med J 1967, 1967(2):724-730.
50. Forbes R.B., Wilson S.V., Swingler R.J. The prevalence of multiple sclerosis in Tayside, Scotland: do latitudinal gradients really exist?. J Neurol 1999, 246(11):1432-1459.
51. Granieri E., Monaldini C., De Gennaro R., Guttmann S., Volpini M., Stumpo M., et al. Multiple sclerosis in the republic of San Marino: a prevalence and incidence study. Mult Scler 2008, 14:325-329.
52. Hammond S.R., de Wytt C., Maxwell I.C., Landy P.J., English D., McLeod J.G., et al. The epidemiology of multiple sclerosis in Queensland, Australia. J Neurol Sci 1987, 80(2-3):185-204.
53. Hammond S.R., McLeod J.G., Millingen K.S., Stewart-Wynne E.G., English D., Holland J.T., et al. The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart. Brain 1988, 111(1):1-25.
54. Hammond S.R., English D., de Wytt C., Maxwell I.C., Millingen K.S., Stewart-Wynne E.G., et al. The clinical profile of MS in Australia: a comparison between medium- and high-frequency prevalence zones. Neurology 1988, 38:980-989.
55. Houzen H., Niino M., Kikuchi S., Fukuzawa T., Nogoshi S., Matsumoto H., et al. The prevalence and clinical characteristics of MS in Northern Japan. J Neurol Sci 2003, 211:49-53.
56. Koch-Henriksen N. The Danish multiple sclerosis registry: a 50-year follow-up. Mult Scler 1999;5(4):293-96.
57. Larsen J.P., Aarli J.A., Nyland H., Riise T. Western Norway: a high-risk area for multiple sclerosis. Neurology 1984, 34:1202-1207.
58. Larsen J.P., Aarli J.A., Nyland H., Riise T. Western Norway, a high-risk area for multiple sclerosis: a prevalence/incidence study in the county of Hordaland. Neurology 1984, 34:1202-1207.
59. Leibowitz U., Kahana E., Alter M. Multiple sclerosis in immigrant and native populations of Israel. Lancet 1969, 1323-1325.
60. Melcon M.O., Gold L., Caceres F., Correale J., Cristiano E., Fernandez Liguori N., et al. Argentine Patagonia: prevalence and clinical features of multiple sclerosis. Mult Scler 2008, 14:656-662.
61. Midgard R., Riise T., Nyland H. Epidemiologic trends in multiple sclerosis in More and Romsdal, Norway. Neurology 1991, 41:887-892.
62. Midgard R., Riise T., Nyland H. Epidemiologic trends in multiple sclerosis in Møre and Romsdal, Norway: a prevalence/incidence study in a stable population. Neurology 1991, 41:887-892.
63. Phadke J.G. Clinical aspects of multiple sclerosis in North East Scotland with particular reference to its course and prognosis. Brain 1990, 113(6):1597-1628.
64. Poser S., Stickel B., Krtsch U., Burckhardt D., Nordman B. Increasing incidence of multiple sclerosis in South Lower Saxony, Germany. Neuroepidemiology 1989, 8:207-213.
65. Poskanzer D.C., Prenny L.B., Sheridan J.L., Kondy J.Y. Multiple sclerosis in the Orkney and Shetland Islands. I: epidemiology, clinicla factors and methodology. J Epidemiol Commun Health 1980, 34:229-239.
66. Radhakrishnan K., Ashok P.P., Sridharan R., Mousa M.E. Prevalence and pattern of multiple sclerosis in Benghazi, North-Eastern Lybia. J Neurol Sci 1985, 70:39-46.
67. Rothwell P.M., Charlton D. High incidence and prevalence of multiple sclerosis in South East Scotland: evidence of a genetic predisposition. J Neurol Neurosurg Psychiat 2008, 64:730-735.
68. Sarasoja T., Wikstrom J., Paltamaa J., Hakama M., Sumelahti M.-L. Occurence of multiple sclerosis in central Finland: a regional and temporal comparison during 30years. Acta Neurol Scand 2004, 110:331-336.
69. Shepherd D.I., Downie A.W. A further prevalence study of multiple sclerosis in north-east Scotland. J Neurol Neurosurg Psychiat 1980, 43:310-315.
70. Skegg D.C.G., Corwin P.A., Craven R.S., Malloch J.A., Pollock M. Occurence of multiple sclerosis in north and south New Zealand. J Neurol Neurosurg Psychiat 1987, 50:134-139.
71. Sundstrom P., Nystrom L., Forsgren L. Prevalence of multiple sclerosis in Vasterbotten Country in northern Sweden. Acta Neurol Scand 2001, 103:214-218.
72. Swingler R.J., Compston D.A.S. The prevalence of multiple sclerosis in South East Wales. J Neurol Neurosurg Psychiat 1988, 51:1520-1524.
73. Totara R., Marini C., Cialfi A., Giunti M., Carolei A. Prevalence of multiple sclerosis in the L'Aquila district, central Italy. J Neurol Neurosurg Psychiat 2000, 68:349-352.
74. Vukusic S., Van Bockstael V., Gosselin S., Confavreux C. Regional variations in the prevalence of multiple sclerosis in French farmers. J Neurol Neurosurg Psychiat 2007, 78(7):707-709.
75. Williams E.S., McKeran R.O. Prevalence of multiple sclerosis in a South London borough. Brit Med J 1986, 293:237-239.
76. Wynn D.R., Rodriguez M., O'Fallon W.M., Kurland L.T. A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota. Neurology 1990, 40:780-786.
77. Wynn D.R., Rodriguez M., O'Fallon W.M., Kurland L.T. A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota. Neurology 1990, 40:780-785.